Global Medical Automation Market revenue is expected to register a CAGR of 7.0% and is anticipated to reach USD 42.28 Billion by 2023. New robotic surgical procedures and increasing healthcare costs are major factors that are driving the demand in this sector.
COVID-19 Analysis The COVID-19 is posing the biggest threat to the healthcare sector in modern years, and digital transformation will climb to the top of the business agenda. The influence of COVID-19 is pervasive, being felt in all major fields of science, politics, and technology. Artificial intelligence and robots are here to stay and their impact on healthcare systems are going to escalate. Health care facilities around the country are facing a shortage due to the overwhelming number of COVID-19 patients. When staffing becomes more limited, software robots and artificial intelligence are used to assist in the distribution of resources, ensure protection and drive efficiencies. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5184 Segmentation The global medical automation market is segmented on the basis of type, and end users. On the basis of type, the market is segmented into diagnostic & monitoring automation, therapeutic automation, lab & pharmacy automation, medical logistics & training, and others. The diagnostic & monitoring automation segment is sub-segmented into automated imaging, point-of-care testing (POCT), automated image analysis, and others. The therapeutic automation segment is sub-segmented into non-surgical automation, surgical automation, and others. The medical logistics & training segment is sub-segmented into logistic automation, trainers, and others. On the basis of end users, the market is segmented into hospitals and diagnostic centers, pharmacies, research labs & institutes, research labs & institutes, and others. Regional Analysis The Americas dominate the global medical automation market owing to an increasing prevalence of the diseases like cancer, diabetes, and others. Moreover, growing biotechnology and biopharmaceutical sector within the region is fuelling the market during the forecast period. In 2016 according to the National Cancer Institute, approximately 1,685,210 new cases of cancer were diagnosed in the United States and approximately 595,690 deaths were reported due to the same, Europe is the second largest market for the global medical automation. The market growth in the European region is facilitated by the presence of developed economies. Huge patient population and rising healthcare expenditure within the region is further fuelling the market growth within the region. In Asia Pacific region growing biotech and biopharmaceutical factor, increasing patient population and rising healthcare expenditures along with the increasing demands for the robotic surgery is driving the market growth. Moreover, favorable government policies are boosting the market growth within the region. The Middle East & Africa & Africa holds the least market share. This can be attributed to the presence of the low per capita income and stringent government policies, especially within the African region. Key Players The key players in the global medical automation market are Koninklijke Philips N.V., Siemens AG, GENERAL ELECTRIC, Medtronic, Stryker, Danaher, Accuray Incorporated, and others. Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/medical-automation-market-5184
0 Comments
The Global Lupus Market is expected to grow significantly over the forecast period. It is anticipated that the market held a market value of USD 1.48 billion in 2017 and is projected to grow at a CAGR of 11.2% over the forecast period. Lupus is a systemic autoimmune disease that causes inflammation throughout the body. In patients with lupus, the immune system attacks healthy cells and tissues of the body which can result in damage to many parts of the body including the skin, joints, kidney, heart, lungs, blood vessels, and brain. The factors such as the rising prevalence of lupus, ongoing medical advancements in the treatment of systemic lupus erythematosus, increasing research and development activities are expected to drive market growth during the forecast period. According to the Lupus Foundation of America, about 1.5 million Americans have a form of lupus, and about 16,000 new cases are reported each year in the Americas. Despite the drivers, the factors such as strict government regulation and increasing prices of lupus drugs may hamper the market growth over the assessment period.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6636 Currently, a large number of companies are present in the lupus market statistics. The prominent market players are involved in the development of new products and product launches. For instance, in July 2017, GlaxoSmithKline received FDA approval for a new self-injectable formulation of Benlysta for the treatment of adult patients with systemic lupus erythematosus. Regional Analysis Geographically, the Americas is expected to dominate the global market owing to the presence of well-developed healthcare sector, rising demand for better treatment options, growing prevalence of lupus, government initiatives for lupus, and availability of reimbursement. Europe is expected to hold the second largest position in the global lupus market owing to the increasing number of research and development activities and the rising prevalence of lupus in the region. Asia-Pacific region is anticipated to be the fastest growing region owing to the growing prevalence of lupus, continuously growing healthcare sector and increasing regional expansion by prominent market players. The Middle East & Africa has the lowest share of the market. Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector. Segmentation The Global Lupus Market has been segmented into type, treatment, and end user. The global market, by types, has been segmented into systemic lupus erythematosus, cutaneous lupus erythematosus, drug-induced lupus erythematosus, and neonatal lupus. The systemic lupus erythematosus segment is expected to hold the largest market share owing to the growing prevalence and increasing drug development in recent years. On the basis of treatment, the global market has been segmented into nonsteroidal anti-inflammatory drugs (NSAIDs), antimalarial drugs, corticosteroids, immunosuppressants, biologics, and other. On the basis of end user, the global market has been segmented into hospital & clinics, diagnostic laboratories, and others. Key Players Some of the prominent players in the global lupus market are Aurinia Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Cadila Healthcare, GlaxoSmithKline plc, Mylan N.V., F. Hoffmann-La Roche AG, Pfizer, Inc., Sanofi, Lycera Corporation, Eli Lily and Company, and Merck KGaA. Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/lupus-market-6636 The global Magnetic Resonance Imaging (MRI) Systems market is expected to be of value USD 5 Billion in 2023 and to grow at a depict 3.5% CAGR during the forecast period. Magnetic resonance imaging (MRI) systems is a non-invasive technique in which light is used to interrogate cellular and molecular function in the living body by exploiting the special properties of photons. Magnetic resonance imaging (MRI) systems are surpassing the radiology imaging market due to its myriad advantages over it. This market is mainly driven by rising demand for non-invasive procedures, harmful effects of radiation-based imaging, increase in research and development activities in the life sciences sector, and increasing application of magnetic resonance imaging (MRI) systems techniques in drug discovery processes and preclinical research, Moreover factors such as rising geriatric population which leads to increase in cardiovascular, neurological and ophthalmic disorders is also fueling the growth of this market. However, the market growth is restricted by factors such as stringent regulatory approval procedures high costs of instruments, scarcity of skilled operators, and insufficient reimbursements policies for magnetic resonance imaging (MRI) systems procedures.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6194 Segmentation The global magnetic resonance imaging (MRI) systems market is segmented on the basis of type, field strength, disease application and end-user. Considering the type, the market is segmented into open MRI, closed MRI, standard bore MRI, wide-bore MRI. On the basis of field strength, the market is segmented into high-field MRI systems, 1.5t MRI systems, 3t MRI systems, low-to-mid-field MRI systems, very-high-field MRI systems, and others. On account of disease application, the market is segmented into spine and musculoskeletal MRI, brain and neurological MRI, pelvic and abdominal MRI, breast MRI, cardiovascular MRI, and others According to the end-user, the market is segmented into diagnostic imaging centers, hospitals and clinics, research laboratories, and pharmaceutical &biotechnology companies. Based on region the market is segmented into Americas, Europe, Asia Pacific, and the Middle East And Africa. Americas region is segmented into North America and South America. Similarly, Europe is segmented into Western Europe and Eastern Europe. Key Players Market Research Future (MRFR) recognizes the following companies as the key players in the magnetic resonance imaging (MRI) systems market trends. Some of the players are Hitachi, Siemens AG, Canon Medical Systems, GE Healthcare, Philips, Toshiba Corporation, Toshiba Corporation, Xingaoyi, Aurora Imaging Technologies, Inc. Regional Analysis Americas is the market leader and has an attractive market for magnetic resonance imaging (MRI) systems owing to increasing prevalence of cardiovascular, neurological and ophthalmic disorders pertaining to rising geriatric population which is a major trigger factor for this disease. Additionally, factors such as increasing government initiatives and funding for research in medical devices sector, rising demand for accurate diagnosis, awareness about adverse effects of radiation imaging, ability to provide in-depth images of soft tissues and vascular systems and presence of pharmaceutical giants also propel the market growth in this region. Europe accounts for the second largest market and holds a healthy share in the global magnetic resonance Imaging (MRI) systems market due to major driving factors like availability of advanced treatment facilities, increasing healthcare expenditure, good healthcare infrastructure and flourishing medical device industry due to the presence of major market players. Additionally, knowledge about the benefits of Magnetic Resonance Imaging (MRI) Systems over radiation imaging and capability of inhabitants to afford the diagnostics is spurring the market growth. Asia Pacific is expected to be the fastest growing market with most promising growth possibilities. According to a report published by the department of neurology in 2014, it is estimated that for the current population of 1.27 billion, approximately 30 million people suffer from neurological disorders in India. Thus, owing to the huge patient pool, a faster adaptation of healthcare technology, government initiatives to increase the healthcare quality, availability favorable insurance policies market growth will be accelerated during the forecast period. Moreover, due to lower cost of clinical trials and research key players have been setting up their regional headquarters and manufacturing plants in Singapore, China, Japan, Korea, and Australia which make a positive growth curve in Magnetic Resonance Imaging (MRI) Systems market in future. The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access and availability of treatment facilities. In the Middle East, the United Arab Emirates and Saudi Arabia is the largest market share owing to the development of healthcare industry and rising availability of specialty care centers. But the market might show steady growth due to and government initiatives to improve quality of healthcare in this region. Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/magnetic-resonance-imaging-market-6194 Neurocutaneous Disorder Market Size of Dynamics, Products, Application Forecast Report 2020-20273/25/2021 The global home healthcare market is anticipated to expand at 8.1% CAGR from 2019 to 2027 (forecast period), according to the latest report by Market Research Future (MRFR). Home healthcare is an increasing viable option being preferred by patients owing to increasing healthcare costs and the burgeoning geriatric population. Home healthcare provides a range of services including physical therapy, speech therapy, occupational therapy, and skilled nursing. The digitization of data has made it simpler for patients to contact physicians and clinicians and gain an accurate diagnosis from the comforts of their home.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2030 Technological advances in healthcare and diagnosis equipment and government initiatives encouraging home healthcare are likely to fuel market demand in the forthcoming years. Taking a cue from patient demands, players such as Philips have launched wireless solutions. This is evident by the introduction of CarePoint 5.0, a easy-to-use nurse call system for senior citizens in assisted living facilities and bedridden patients recuperating at home. But concerns regarding patient safety can impede market growth. Home Healthcare Market OverviewThe report covers the latest trends affecting the home healthcare industry to provide the most accurate forecasts and predictions. By correlating the historical data with key market dynamics, our analysts can make highly astute projections. MRFR’s report includes a thorough analysis of the global home healthcare market segmented by product, service, software, and region. Trends and opportunities are highlighted coupled with the market share of companies as well as their valuation in the market. It analyzes new revenue sources for players and outlines the various strategies implemented by players. The growing geriatric population in the market will support the growth. As per market analysts, the home healthcare market based companies will face certain challenges during the forecast period 2019 to 2027. The market research report provides in-depth analysis of the product, service, software, and region segments. The market research report presents factors such as the rise of IoT that could slow down the market's growth. Market Segmentation The home healthcare market has been segmented into product, service, software, and region. Based on the segment which is the product, the home healthcare market is categorized on the basis of therapeutic products and others. The global market for home healthcare is further segmented based on service into respiratory therapy service, skilled nursing services, and others. Furthermore, the market, on the basis of software, is segmented into telehealth solutions, clinical management systems, and others. The market report offers comprehensive study of the market segments including product, service, software, and region. The analysts have also studied the market's spread across the regional markets across many of the market’s segments at country levels. The product, service, software, and region segments spread across the market along with the subsegments are studied. The global home healthcare market for home healthcare is spread across various product and service based segments. The market research report highlights these key segments and offers forecasts based on primary and secondary data. The global home healthcare market research report presents key company profiles of organizations active across the market. Regional Overview Concerns regarding safety and authenticity of treatment may hinder the home healthcare market growth. The market research report suggests that companies in the market could be supported by new revenue sources being utilized by market players as well as the growing investment during the forecast period. The market is set to register growth at a high CAGR owing to these key factors. The market is spread across North America, Europe, Asia-Pacific, and other parts of the world. As per market analysts, the home healthcare market is set to witness tremendous growth across product, service, software, and region segments. The global market’s North American region covers markets across the United States, Mexico, Canada, and others. Businesses present in the market are also profiled and their strategies have been presented in detail in the market research report. The home healthcare market across the European region covers Italy, France, Germany, and the United Kingdom. Furthermore, the market research report provides details about the APAC region covering markets from China, India, Australia, Japan, and others. The market is also active across several other parts of the world. The market report covers all these key regions including the Middle East, Africa, Brazil, and others active in the global home healthcare market. Competitive Landscape Home healthcare has seen tremendous growth, due to growing prevalence of diseases and development of modern technologies. However, lack of infrastructure and high cost associated with products and services would challenge the companies active in the market. Furthermore, companies using growth strategies to stay ahead in the global home healthcare market are expected to help the market during the forecast period 2019 to 2027. As the market report suggests that the market will register a CAGR of 8.1% and reach a US$4,14,681.2 million by 2023, the market report highlights key areas market based companies need to focus on. The home healthcare market research report projects a long term growth till 2027. Based on market’s analysis on the basis of SWOT and Porters’ Five Force Model, the market will rise during the forecast period 2019 to 2027, however the companies need to move ahead with caution. The market research report highlights such key areas. Industry News The agency is seeking to develop relationships with clinics and health departments, the organisations have just reported. Bayada Home Health Care will purchase a Visiting Nurse Group Health Care fellow home health provider. The home health, hospice and physician services departments of the Holmdel Association of Visiting Nurses will be incorporated into Bayada's operations, while the community chair of the Bayada Hospice Wellbeing and the hospice Specialties, including all the hospital relationships, is served by Dr Steven Landers, President and CEO of VNAHG. Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/home-Healthcare-market-2030 Acute myeloid leukemia (AML) is a cancer of the myeloid blood cells, causing extreme and rapid growth of abnormal white blood cells of the bone marrow. The rapid buildup of abnormal white blood cells causes interference in the production of normal blood cells. AML has a propensity to increase towards age. Replacement of normal bone marrow with cancer cells causes a drop in blood constituents such as red blood cells, platelets, white blood cells etc. which causes symptoms such as fatigue, breathlessness, easy bruising and bleeding, and increased risk of infection. The market driving factors for acute myeloid leukemia (AML) are rise in risk factors such as exposures to carcinogens such as ionizing radiation, chemicals etc. Presence of other blood disorders and genetics is also involved for the higher risk of AML. Other market drivers are increasing number of cancer hospitals, greater awareness, good reimbursement scenario etc. The market constraints are poor cure rates of the present drugs, serious side effects of the drugs etc.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/3223 Considering all these factors the market for acute myeloid leukemia treatment is expected to reach $ 1.2 billion by the end of 2023, this market is projected to growing at a CAGR of Approx 5.3 % during 2017-2023. Key players of Global Acute Myeloid Leukemia Treatment Market Key players profiled in the report are Johnson & Johnson, Pfizer Inc., Celgene Corporation, Ambit Biosciences Corporation, Cyclacel Pharmaceuticals Inc. Novartis AG and Sanofi, Bristol Myers Squibb and others. Segments The global acute myeloid leukemia treatment market is segmented on the basis of disease type. Based on the disease type, the market has been segmented as myeloblastic, promyeloctic, myelomonocytic, monocytic, erythroleukemia and megakaryocytic. Based on the treatment, the market has been segmented as chemotherapy, and hematopoietic stem cell transplantation. Chemotherapy is further sub-segmented into induction and post remission. Intended Audience
US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. Europe is the second largest market due to large disposable income and presence of large hospitals. Asia pacific region will be the fastest region because of large unmet needs which will be led by China and India. The Middle East and Africa market will be led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa is expected to be a laggard due to poor economic and political conditions. The report for Global Acute Myeloid Leukemia (AML) Therapeutics Market by Market Research Future comprises of extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions. Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/acute-myeloid-leukemia-treatment-market-3223 Global Patient Handling Equipment Market size is expected to be valued at USD 15,430.18 Million by 2027 at a CAGR of 8.3% during the forecast period, 2020-2027.
The advancement in patient handling equipment and expansion of healthcare infrastructure due to the COVID-19 pandemic is expected to boost the growth of the market in the forecast period. Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/9986 An increasing usage of patient handling equipment in hospitals, rehabilitation centers, and elderly care settings is expected to drive the growth of the global patient handling equipment market. The market growth in the coming years can also be attributed to the business expansion of manufacturers through merger & acquisition and incessant launch of innovative products. For instance, in the year 2020, Invacare Corporation, a US-based long-term medical product manufacturer, announced the launch of an Invacare AVIVA FX Power Wheelchair, a front-wheel-drive wheelchair. This product launch was aimed to strengthen the company’s power mobility product portfolio. Market USP Growing patient population of chronic diseases and rising geriatric population are the major market influencer of the patient handling equipment market. Market Drivers The rising influx of patients in the hospital due to an outbreak of COVID-19 pandemic. The critical care products including hospital beds, ventilators, and vitals monitoring devices are being used in abundance for patients suffering from COVID-19. Various companies are aiding the healthcare sector in meeting the rising demand for critical care products by increasing their manufacturing capacity. For instance, in May 2020, Stryker (US) delivered about 1,000 emergency relief beds to hospitals in Qatar. The company is also massively producing emergency relief beds, a low-cost hospital bed.
By Product
Nebulizers are a device that has the capability of changing a medication from a liquid to a mist so that it can be inhaled into the lungs. High demand for respiratory devices, including nebulizers, due to the outbreak of COVID-19 globally, growing need for rescue medication, increasing prevalence of respiratory diseases, and rising demand for home healthcare devices are the key factors that are expected to drive the market growth. Moreover, the growing geriatric population, increasing consumption of alcohol, tobacco, cigarettes, and other such products may lead to respiratory diseases, and the rising number of initiatives taken by the government as well as the private organizations are also expected to boost the market growth.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/9586 According to MRFR analysis, the Global Nebulizers Market size is expected to register a CAGR of 7.32% during the forecast period of 2020 to 2027 and reach USD 1,629.7 Million by 2027. A nebulizer is a type of breathing machine that is used to take inhaled medicines. Nebulizer treatment is carried out with an air compressor machine. The growth of the global nebulizers market can be contributed to the growing need for rescue medication, high demand for respiratory devices, including nebulizers, due to outbreak of COVID-19 globally, and increasing prevalence of chronic respiratory diseases. According to a press release from Icon Plc in April 2020, the demand for respiratory devices has enormously increased, due to the rising cases of COVID-19. Furthermore, the growing demand for home healthcare devices, rising geriatric population, increasing consumption of alcohol, tobacco, cigarettes, and other such products that might lead to respiratory diseases, are also expected to fuel the market growth during the forecast period. However, the loss of drug during nebulization procedures, availability of various substitutes for nebulizers, and side effects of nebulizer solutions are expected to restrain the growth of the global nebulizers market. Several market players such as OMRON Healthcare, Koninklijke Philips N.V., and B. Braun Melsungen AG, among others currently dominate the global nebulizers market. The key players are involved in awareness campaigns, product approvals, mergers, and strategic collaborations to strengthen their market positions. For instance, in April 2020, B. Braun Melsungen AG received the Food and Drugs Administration (FDA) emergency use authorization for using its infusion pumps with nebulizers to treat COVID-19 patients. Regional Analysis The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region held the largest market in 2019, owing to the rising demand for respiratory diseases in the region. The nebulizers market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European nebulizers market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The nebulizers market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing incidence rate of respiratory diseases, the market in Asia-Pacific is expected to be the fastest-growing. The nebulizers market in the Middle East & Africa has been divided into the Middle East and Africa. Segmentation The Global Nebulizers Market has been Segmented Based on the Type, Usage, Portability, and End User. Based on the Type, the global nebulizers market has been segmented into mesh, jet, and ultrasonic. The mesh segment is further divided into active and passive. The jet segment is expected to hold the largest market share owing to its low cost as compared to other types of nebulizers. On the basis of usage, the market has been segmented into reusable and disposable. The disposable nebulizers are expected to hold a major market share owing to their growing popularity amongst the users. Based on the portability, the market has been segmented into tabletop and portable. The portable nebulizers market is expected to grow at the fastest CAGR owing to its ease and convenience of use. The market based on end-user has been segmented into hospitals & clinics, home care, and others. The hospitals and clinics segment is expected to hold the largest market share owing to the larger patient footfall in hospitals. Key Players Some of the key players in the global nebulizers market are OMRON Healthcare (Japan), Koninklijke Philips N.V. (Netherlands), PARI (US), Vectura Group plc (UK), Rossmax International Ltd (Taiwan), Briggs Healthcare (US), GF Health Products, Inc. (US), Beurer GmBH (Germany), Agilent Technologies, Inc. (US), Drive DeVilbiss Healthcare (US), Invacare Corporation (US), and B. Braun Melsungen AG (Germany). Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/nebulizers-market-9586 |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
June 2021
Categories |